logo

Biogen Inc. (BIIB)



Trade BIIB now with
  Date
  Headline
7/20/2022 8:06:00 AM Biogen Inc. (BIIB) Has Raised Its FY22 EPS Estimate To 15.25 - 16.75 From 14.25 - 16.00
7/20/2022 7:07:59 AM Biogen Q2 GAAP EPS $7.24; Non-GAAP EPS $5.25
6/3/2022 8:19:47 AM Biogen Present Positive Phase 3 Data For Tocilizumab Biosimilar Candidate In Rheumatoid Arthritis
5/3/2022 7:16:47 AM Biogen Q1 GAAP EPS $2.06; Non-GAAP EPS $3.62
5/2/2022 6:36:06 AM Sage Therapeutics, Biogen Begin Rolling Submission Of NDA To US FDA For Zuranolone For Potential Treatment Of MDD
3/30/2022 7:46:04 AM Biogen Submits Final Protocol For ADUHELM Phase 4 ENVISION Trial To FDA
3/28/2022 7:34:53 AM Biogen : Phase 1 Study Of BIIB078 On Amyotrophic Lateral Sclerosis Did Not Meet Any Secondary Efficacy Endpoints
3/16/2022 7:40:48 AM Biogen Inc. Announces Data From Long-term Extension Study Of ADUHELM